Stocks › KOD
Kodiak Sciences Inc.
KOD·Nasdaq·
United States·USD
United States·USD$92.34
-1.47 (-1.57%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
KOD
Kodiak Sciences Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
KODS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of KOD by members of U.S. Congress · 2 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Christopher L. JacobsHouse · R · NY |
KODKodiak Sciences Inc. · Stock |
Sale $1,001 - $15,000 |
Dec 12, 2022 | Nov 8, 2022 | Filing ↗ |
| Christopher L. JacobsHouse · R · NY |
KODKodiak Sciences Inc. · Stock |
Purchase $1,001 - $15,000 |
Sep 9, 2022 | Jul 18, 2022 | Filing ↗ |
Whale Activity
Position changes in KOD reported for 2026-06-30 by 11 tracked institutional filers
- Increased5
- New0
- Held1
- Decreased4
- Closed0
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 4.1M | $161.1M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $70.3M | increased |
| ICONIQ Capital, LLC | 1.3M | $49.3M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 532.8K | $20.8M | increased |
| TWO SIGMA INVESTMENTS, LP | 473.0K | $18.4M | increased |
| D. E. Shaw & Co., Inc. | 211.3K | $8.2M | decreased |
| RENAISSANCE TECHNOLOGIES LLC | 189.2K | $7.4M | decreased |
| CITADEL ADVISORS LLC | 157.5K | $6.1M | decreased |
| Bruce & Co., Inc. | 145.0K | $5.6M | held |
| Point72 Asset Management, L.P. | 97.6K | $3.8M | decreased |
| MILLENNIUM MANAGEMENT LLC | 31.2K | $1.2M | increased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by KOD insiders, by quarter · Form 4
Recent Insider Transactions
535 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +84 | $85.89 | $7K | Sep 29, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +619 | $84.24 | $52K | Sep 29, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +20.0K | $85.40 | $1.7M | Sep 29, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +1,416 | $85.89 | $122K | Sep 29, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +1,195 | $85.40 | $102K | Sep 29, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +10.4K | $84.24 | $875K | Sep 29, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +98.6K | $88.57 | $8.7M | Sep 28, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +957 | $86.81 | $83K | Sep 28, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +82.7K | $89.60 | $7.4M | Sep 28, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +75.2K | $87.51 | $6.6M | Sep 28, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +6,428 | $88.65 | $570K | Sep 28, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +63.5K | $86.94 | $5.5M | Sep 28, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +5,880 | $88.57 | $521K | Sep 28, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +4,932 | $89.60 | $442K | Sep 28, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +4,485 | $87.51 | $392K | Sep 28, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +3,790 | $86.94 | $330K | Sep 28, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +3,114 | $86.72 | $270K | Sep 28, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +196.6K | $89.86 | $17.7M | Sep 28, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +186 | $86.72 | $16K | Sep 28, 2026 | Form 4 ↗ |
| BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director | Purchase | +16.0K | $86.81 | $1.4M | Sep 28, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding KOD · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1.5M | $58.3M | 0.54% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.3M | $50.2M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 1.0M | $39.8M | 0.05% | Jun 30, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 1.0M | $39.5M | 0.33% | Jun 30, 2026 |
| Artisan International Small-Mid Fund Artisan Partners Funds Inc. | 596.0K | $23.2M | 0.91% | Jun 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 590.8K | $23.0M | 0.16% | Jun 30, 2026 |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 498.3K | $19.4M | 0.20% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 475.6K | $18.5M | 0.02% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 430.5K | $17.9M | 0.05% | Jul 31, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 426.5K | $16.6M | 0.18% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list KOD's shares (CUSIP 50015M109), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Felix J. BakerSCHEDULE 13D/A · activist (13D) · 22.0M shares35.0%
Sep 30, 2026 · ↗ - Julian C. BakerSCHEDULE 13D/A · activist (13D) · 22.0M shares35.0%
Sep 30, 2026 · ↗ - Baker Bros. Advisors (GP) LLCSCHEDULE 13D/A · activist (13D) · 22.0M shares35.0%
Sep 30, 2026 · ↗ - Baker Bros. Advisors LPSCHEDULE 13D/A · activist (13D) · 22.0M shares35.0%
Sep 30, 2026 · ↗ - T. Rowe Price Associates, Inc.SCHEDULE 13G · passive (13G) · 3.2M shares5.2%
Aug 14, 2026 · ↗ - Alex SilversteinSCHEDULE 13G · passive (13G) · 3.5M shares5.7%
May 15, 2026 · ↗ - Sirenia Capital Management LPSCHEDULE 13G · passive (13G) · 3.5M shares5.7%
May 15, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming Kodiak Sciences Inc. as client
No lobbying filings found naming Kodiak Sciences Inc. as the client.
Government Contracts
Federal awards to Kodiak Sciences Inc. · USAspending
No federal contract awards found for Kodiak Sciences Inc..
U.S. Patents
Recent USPTO applications naming Kodiak Sciences Inc.
No USPTO patent applications found for Kodiak Sciences Inc..
Annual Financials
From KOD's 10-K filings · XBRL
No annual XBRL figures on record for KOD. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in KOD's price history.
About Kodiak Sciences Inc.
From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersPALO ALTO, CA
IncorporatedDE
SEC CIK0001468748 ↗
Former namesOligasis, LLC